Seasonal variation of relapse rate in multiple sclerosis is latitude dependent

Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis

(2013) Robert Zivadinov et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Vitamin D status: Multifactorial contribution of environment, genes and other factors in healthy Australian adults across a latitude gradient

(2013) Robyn M. Lucas et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Pharmacoepidemiology and the Australian regional prevalence of multiple sclerosis

(2013) Samantha Hollingworth et al.   Multiple Sclerosis Journal

Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial

(2012) Hajar Derakhshandi et al.   ACTA NEUROLOGICA BELGICA

Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis

(2012) Ellen M. Mowry et al.   ANNALS OF NEUROLOGY

A randomised, double blind, placebo controlled trial with vitamin D3as an add on treatment to interferon β-1b in patients with multiple sclerosis

(2012) Merja Soilu-Hänninen et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation

(2012) Charles Pierrot-Deseilligny et al.   Therapeutic Advances in Neurological Disorders

Seasonal Variation in 25-Hydroxyvitamin D Concentrations in the Cardiovascular Health Study

(2011) A. B. Shoben et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Regulation of Immune Responses by Prostaglandin E2

(2011) P. Kalinski   JOURNAL OF IMMUNOLOGY

Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis

(2011) S. Simpson et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Efficacy of vitamin D3 as add-on therapy in patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial

(2011) Joost Smolders et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Latitudinal prevalence gradient of multiple sclerosis in Latin America

(2011) J Risco et al.   Multiple Sclerosis Journal

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis

(2011) M. S. Stein et al.   NEUROLOGY

UV-induced immunosuppression and the efficacy of vaccination

(2011) Mary Norval et al.   PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES

The Consequences of UV-Induced Immunosuppression for Human Health

(2011) Mary Norval et al.   PHOTOCHEMISTRY AND PHOTOBIOLOGY

Widespread vitamin D insufficiency: A new challenge for primary prevention, with particular reference to multiple sclerosis

(2011) Charles Pierrot-Deseilligny et al.   PRESSE MEDICALE

Vitamin D: Evolutionary, Physiological and Health Perspectives

(2010) Michael F. Holick   CURRENT DRUG TARGETS

Ultraviolet Irradiation of Mice Reduces the Competency of Bone Marrow-Derived CD11c+ Cells via an Indomethacin-Inhibitable Pathway

(2010) R. L. X. Ng et al.   JOURNAL OF IMMUNOLOGY

Serum 25-Hydroxyvitamin D and the Incidence of Acute Viral Respiratory Tract Infections in Healthy Adults

(2010) James R. Sabetta et al.   PLoS One

Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis

(2008) J Smolders et al.   Multiple Sclerosis Journal

Vitamin D: A Candidate for the Environmental Effect in Multiple Sclerosis – Observations from Norway

(2008) Margitta T. Kampman et al.   NEUROEPIDEMIOLOGY

Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis

(2008) T. Hagenau et al.   OSTEOPOROSIS INTERNATIONAL